Clinical trial

Sevoflurane Versus Intravenous Anaesthetic Agents in Morbid Obese Patients

NCT01279499

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Sevoflurane Normalized identity: sevofluraneView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Propofol- Remifentanyl Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Propofol, Remifentanyl Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Sevoflurane Versus Intravenous Anaesthetic Agents in Morbid Obese Patients

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2, PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2010-04-01

PhasePHASE2 / PHASE3

Conditions

Morbid Obesityverified · MONDO: morbid obesity

Interventions

SevofluraneDRUG · verified · RxNorm: sevoflurane

Propofol- RemifentanylDRUG

Propofol, RemifentanylDRUG

Sponsors & collaborators

University of Patraslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01279499 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.